About

The Aenova Group is a leading global contract manufacturer and development services provider for the pharmaceutical and healthcare industry. Our services include end-to-end manufacturing and development of all dosage forms and potency levels (ranging from nutraceuticals to high-potents) out of 15 sites in Europe and the US. Aenova can offer sterile compounding and filling of liquids in Pre-Filled Syringes, either aseptically filled or terminally sterilized, on filling lines equipped with barrier technology (RABS or Isolators). Aenova is the ideal partner for development and production of virtually all types of solid dosage forms and APIs up to OEB 5. Aenova has more than 35 years of experience in the formulation and analytical development and production of soft gelatin capsules. Our production facilities are equipped with state-of-the-art equipment to process any formulation and any capsule design, color and size. With development and manufacturing capacities including high potent active pharmaceutical drugs at our Center of Excellence in Kirchberg/Switzerland also with the ability to manufacture with high potent active pharmaceutical ingredients which can be handled within adequate equipment like gloveboxes for OEB 5 level and closed process tank systems. With our comprehensive know-how, many years of experience, well-trained staff of 4,200 employess, innovative technologies and highest quality standards we are a reliable, long-term partner to pharmaceutical and consumer health care customers around the world, both in the human and veterinary healthcare market. About Aenova The Aenova Group is a leading global contract manufacturer and development services provider for the pharmaceutical and healthcare industry. Our services include end-to-end manufacturing and development of all dosage forms and potency levels (ranging from nutraceuticals to high-potents) out of 15 sites in Europe and the US. Aenova can offer sterile compounding and filling of liquids in Pre-Filled Syringes, either aseptically filled or terminally sterilized, on filling lines equipped with barrier technology (RABS or Isolators). Aenova is the ideal partner for development and production of virtually all types of solid dosage forms and APIs up to OEB 5. Aenova has more than 35 years of experience in the formulation and analytical development and production of soft gelatin capsules. Our production facilities are equipped with state-of-the-art equipment to process any formulation and any capsule design, color and size. With development and manufacturing capacities including high potent active pharmaceutical drugs at our Center of Excellence in Kirchberg/Switzerland also with the ability to manufacture with high potent active pharmaceutical ingredients which can be handled within adequate equipment like gloveboxes for OEB 5 level and closed process tank systems. With our comprehensive know-how, many years of experience, well-trained staff of 4,200 employess, innovative technologies and highest quality standards we are a reliable, long-term partner to pharmaceutical and consumer health care customers around the world, both in the human and veterinary healthcare market. About Aenova Aenova is one of the leading contract development and manufacturing organizations (CDMOs) in the global pharmaceutical supply chain. They provide services covering the entire value chain from development to commercialization for all common product groups and dosage forms (solid, semisolid, sterile, and nonsterile liquid). The company supplies drugs up to OEB 5 and food supplements for both human and veterinary use. They are also able to handle differentiated technologies such as HPAPI containment, low-dose, modified release formulations, organic granulation, particulate systems, lipid-based formulas, HME or spray drying for poorly soluble compounds. Aenova offers customers a wide-ranging service portfolio and challenges itself to expedite time to market and facilitate the drug development journey. The one-stop-shop experience stretches from early phase formulation and product development to the purchase of raw materials, analytics, regulatory support, small and full-scale production, market release through to packaging and logistics. Aenova develops, produces and packages across a network of 14 sites in the US, Germany, Switzerland, Italy, Ireland, and Romania, with headquarters near Munich, Germany. The manufacturing sites are complemented by seven specialized Development Competence Centers for various technologies and dosage forms that support clients with tailormade solutions. A highly motivated international team of nearly 4,000 employees from over 50 nations contributes to the group’s strong, long-lasting customer partnerships and continuous development. Excellence & Reliability are anchored in the company culture as core values, benefiting customers in the shape of ample capacities, back-up sourcing within the group, and continued capital investment in capacities and capabilities. In line with a “Customers & Patients first” mentality, a dedicated Business Management team is in place to provide personalized customer service, address needs and solve potential issues efficiently. Aenova’s client base consists of most of the leading global players in pharmaceuticals, consumer healthcare, veterinary health and dietary supplements, as well as many small and mid-size pharma and biotech companies. Surveys show that the majority of the group’s clients consider Aenova their preferred supplier and report a strong overall satisfaction in working with the group. Aenova Group – CDMO Value Creation Across the Entire Product Lifecycle Aenova is one of the leading contract development and manufacturing organizations (CDMOs) in the global pharmaceutical supply chain. They provide services covering the entire value chain from development to commercialization for all common product groups and dosage forms (solid, semisolid, sterile, and nonsterile liquid). The company supplies drugs up to OEB 5 and food supplements for both human and veterinary use. They are also able to handle differentiated technologies such as HPAPI containment, low-dose, modified release formulations, organic granulation, particulate systems, lipid-based formulas, HME or spray drying for poorly soluble compounds. Aenova offers customers a wide-ranging service portfolio and challenges itself to expedite time to market and facilitate the drug development journey. The one-stop-shop experience stretches from early phase formulation and product development to the purchase of raw materials, analytics, regulatory support, small and full-scale production, market release through to packaging and logistics. Aenova develops, produces and packages across a network of 14 sites in the US, Germany, Switzerland, Italy, Ireland, and Romania, with headquarters near Munich, Germany. The manufacturing sites are complemented by seven specialized Development Competence Centers for various technologies and dosage forms that support clients with tailormade solutions.